SCHEMBL5162641

SCHEMBL5162641

Nc1ccc(O)cc1CC(=O)NCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
LMNA P02545 1/20 0.51
ERCC1 P07992 1/20 0.51
ERCC4 Q92889 1/20 0.51
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
HSD17B2 P37059 1/20 0.51
GAA P10253 2/20 0.50
RAB9A P51151 2/20 0.50
TRPV1 Q8NER1 1/20 0.50
MAPT P10636 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
HDAC1 Q13547 3/20 0.49
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15243433 0.85 ERCC1 (0.61) ALDH1A1LMNAERCC1ERCC4CA1
SCHEMBL6962946 0.83 ALDH1A1 (0.58) ALDH1A1LMNACA1CA2GAA
SCHEMBL3815239 0.81 CYP1A2 (0.53) LMNAL3MBTL1HDAC1HDAC3HDAC4
SCHEMBL5162190 0.80 MEN1 (0.40) HPGDMEN1KMT2A
SCHEMBL5159764 0.80 POLB (0.59) GAARAB9AMAPTL3MBTL1HDAC1
SCHEMBL5160286 0.79 PDK2 (0.38) CA1CA2TRPV1CDK5CDK5R1
SCHEMBL5164514 0.79 CNR2 (0.39) ALDH1A1GAATRPV1MAPTCDK5
Ammonia Solution, Strong SCHEMBL5159774 0.79 POLB (0.58) GAARAB9AMAPTL3MBTL1HDAC1
SCHEMBL16747758 0.78 CA1 (0.64) ALDH1A1LMNAERCC1ERCC4CA1
SCHEMBL5164574 0.78 HPGD (0.53) ALDH1A1LMNAGAARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP claimed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP disclosed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds KRT18, S100A4, CKAP4 ALDH1A1 309/4885LMNA 1433/4885ERCC1 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.